Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Shares Outstanding (2023 - 2025)

GE HealthCare Technologies' Shares Outstanding history spans 3 years, with the latest figure at $458.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding changed 0.35% year-over-year to $458.8 million, compared with a TTM value of $458.8 million through Dec 2025, changed 0.35%, and an annual FY2025 reading of $458.8 million, changed 0.35% over the prior year.
  • Shares Outstanding for Q4 2025 was $458.8 million at GE HealthCare Technologies, roughly flat from $458.6 million in the prior quarter.
  • The five-year high for Shares Outstanding was $458.8 million in Q4 2025, with the low at $455.0 million in Q1 2023.
  • Average Shares Outstanding over 3 years is $456.7 million, with a median of $457.0 million recorded in 2024.
  • Year-over-year, Shares Outstanding increased 0.49% in 2024 and then increased 0.22% in 2025.
  • Tracing GEHC's Shares Outstanding over 3 years: stood at $455.0 million in 2023, then increased by 0.49% to $457.2 million in 2024, then grew by 0.35% to $458.8 million in 2025.
  • Per Business Quant, the three most recent readings for GEHC's Shares Outstanding are $458.8 million (Q4 2025), $458.6 million (Q3 2025), and $458.0 million (Q2 2025).